Shingles Vaccine- Zostavax
A vaccine for shingles (Zostavax) was licensed in 2006.
In clinical trials, the vaccine prevented shingles or reduced the symptoms in about half of people 60 years of age and older. It can also reduce the severe pain associated with Shingles.
Someone with a minor illness, such as a cold may be immunized but anyone who is moderately or severely ill should usually wait until they recover before getting the vaccine.
Common Side Effects:
- Redness, soreness, swelling, or itching at the site of the injection (about 1 person in 3)
- Headache (about 1 person in 70)
- No serious problems have been identified with shingles vaccine.
For more detailed information on shingles, click here.